FUSMobile

Focused Ultrasound Therapy for Chronic Pain

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2014 by Arik Hanannel and Ron Aginsky, FUSMobile operates with 11–50 employees. The company has completed one disclosed funding round. In July 2017, FUSMobile secured funding from investor OrbiMed.

Business overview

FUSMobile is a Health Tech & Life Sciences company focused on developing non-invasive solutions for chronic painful conditions. Its core product, Neurolyser, is a focused ultrasound treatment platform designed to thermally ablate nerves, targeting conditions such as chronic lower back pain, knee and hip arthritis, sacroiliitis, and bone metastases. The company aims to improve patient experience and clinical outcomes while reducing healthcare costs for providers and payers, operating within the Medical Devices and Medical Treatment & Therapeutics sectors.

Strategic signal

In October 2017, FUSMobile initiated a clinical trial in Canada for facet arthritis low back pain, utilizing its Neurolyser XR focused ultrasound device. This development signals the company's progress in clinical validation and its strategic move towards regulatory approval and market entry for its non-invasive pain treatment technology, positioning it as a potential disruptor in the interventional pain management landscape.

Company Intelligence Q&A

What is FUSMobile's primary focus?
FUSMobile focuses on advancing non-invasive solutions for chronic painful conditions to improve patient experience and clinical outcomes while reducing costs for healthcare providers and payers.
What is the Neurolyser?
The Neurolyser is FUSMobile's focused ultrasound treatment platform designed to relieve suffering caused by common conditions like chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases.
When did FUSMobile begin a clinical trial for facet arthritis low back pain?
In October 2017, FUSMobile began a clinical trial in Canada for facet arthritis low back pain using its Neurolyser XR focused ultrasound device.
Who are the co-founders of FUSMobile?
FUSMobile was co-founded by Arik Hanannel, who serves as CEO, and Ron Aginsky, who serves as President.